Agendia to Reveal Novel Breast Cancer Outcome Data Identifying Genomic Risk and Treatment Disparities Among Diverse Patient Population at 2025 ASCO Annual Meeting

FLEX Study Highlights Clinical Utility of MammaPrint® and BluePrint® Read More

2025-06-18T14:05:14-04:00May 27th, 2025|Press Releases|
Go to Top